coIMMUNE appoints Dr. Ed Baracchini to its Board of Directors

– USA, NC –  CoImmune, Inc., a clinical-stage immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the appointment of Dr.